Prodromal AD


The following are ongoing clinical trials carried out a various C5R sites involving subjects with Prodromal Alzheimer’s disease.

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) (APECS)

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease (ExpeditionPRO)